1. Home
  2. GEOS vs IOVA Comparison

GEOS vs IOVA Comparison

Compare GEOS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • IOVA
  • Stock Information
  • Founded
  • GEOS 1980
  • IOVA 2007
  • Country
  • GEOS United States
  • IOVA United States
  • Employees
  • GEOS N/A
  • IOVA N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GEOS Industrials
  • IOVA Health Care
  • Exchange
  • GEOS Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • GEOS 72.9M
  • IOVA 771.4M
  • IPO Year
  • GEOS 1997
  • IOVA N/A
  • Fundamental
  • Price
  • GEOS $13.91
  • IOVA $1.71
  • Analyst Decision
  • GEOS
  • IOVA Buy
  • Analyst Count
  • GEOS 0
  • IOVA 10
  • Target Price
  • GEOS N/A
  • IOVA $12.22
  • AVG Volume (30 Days)
  • GEOS 462.9K
  • IOVA 11.8M
  • Earning Date
  • GEOS 08-07-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • GEOS N/A
  • IOVA N/A
  • EPS Growth
  • GEOS N/A
  • IOVA N/A
  • EPS
  • GEOS N/A
  • IOVA N/A
  • Revenue
  • GEOS $116,542,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • GEOS N/A
  • IOVA $86.62
  • Revenue Next Year
  • GEOS N/A
  • IOVA $69.95
  • P/E Ratio
  • GEOS N/A
  • IOVA N/A
  • Revenue Growth
  • GEOS N/A
  • IOVA 11070.12
  • 52 Week Low
  • GEOS $5.51
  • IOVA $1.64
  • 52 Week High
  • GEOS $18.99
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 74.70
  • IOVA 36.89
  • Support Level
  • GEOS $15.31
  • IOVA $1.95
  • Resistance Level
  • GEOS $18.99
  • IOVA $2.47
  • Average True Range (ATR)
  • GEOS 1.44
  • IOVA 0.16
  • MACD
  • GEOS 0.96
  • IOVA -0.00
  • Stochastic Oscillator
  • GEOS 76.70
  • IOVA 6.41

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: